ADAPTIVE TCR CORPORATION

Basic Information

1551 Eastlake Avenue East
Suite 200
SEATTLE, WA, 98102-

Company Profile

n/a

Additional Details

Field Value
DUNS: 832591544
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Non-invasive Diagnostic Platform Development for Celiac Disease Remission Status

    Amount: $244,699.00

    DESCRIPTION (provided by applicant): The purpose of this proposal is to adapt a technology that we have developed for monitoring residual disease in leukemia patients to monitor residual autoimmune di ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling

    Amount: $165,191.00

    DESCRIPTION (provided by applicant): Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling T-cell neoplasms are generally more aggressive and have poorer outcomes than comparable ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Correlating TCR diversity to immune reconstitution after cord blood transplant

    Amount: $2,528,467.00

    DESCRIPTION (provided by applicant): Many patients requiring stem cell transplantation for hematological malignancies are unable to find a suitable HLA-matched sibling or unrelated donor. Transplants ...

    SBIR Phase II 2013 Department of Health and Human Services
  4. SBIR TOPIC 315: DEVELOPMENT OF COMPANION DIAGNOSTICS: ENABLING PRECISION MEDICINE

    Amount: $266,199.00

    Immunotherapy has emerged as a promising method to treat several cancers. In 2012 the FDA approved a new immunotherapy agent, ipilimumab, for metastatic melanoma. Ipilimumab activates T-cells and glob ...

    SBIR Phase I 2013 Department of Health and Human Services
  5. Correlating TCR diversity to immune reconstitution after cord blood transplant

    Amount: $2,008,708.00

    DESCRIPTION provided by applicant Many patients requiring stem cell transplantation for hematological malignancies are unable to find a suitable HLA matched sibling or unrelated donor Transplants ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  6. Correlating TCR diversity to immune reconstitution after cord blood transplant

    Amount: $148,999.00

    DESCRIPTION (provided by applicant): The goal of this Phase I project is to develop a method to objectively measure immune reconstitution following hematopoietic stem cell transplantation using direc ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Development of T-cell receptor repertoire profiling as a diagnostic for T1D

    Amount: $632,685.00

    DESCRIPTION (provided by applicant): The goal of this Phase I project is the identification of a molecular signature in the T-cell receptor repertoire of early-stage Type 1 Diabetes (T1D) patients th ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government